The protease inhibitor is specifically intended for non-hospitalized, symptomatic adults who have a confirmed COVID-19 infection and are not believed to be at increased risk for progression to severe illness.  A controlled study is underway.

Recommended.

https://www.lewrockwell.com/2021/09/no_author/no-need-to-wait-for-big-pharmas-anti-covid-protease-inhibiting-drug/